© The Rockefeller University Press, 0022-1007/1997/2/629/ $5.00
The Journal of Experimental Medicine, Volume 185, Number 4, February 17, 1997 629-640
Effects of Epitope Modification on T Cell Receptor–Ligand Binding and Antigen Recognition by Seven H-2Kd–restricted Cytotoxic T Lymphocyte Clones Specific for a Photoreactive Peptide Derivative
Benedikt M. Kessler,
Paolo Bassanini,
Jean-Charles Cerottini, and
Immanuel F. Luescher
From the Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, 1066 Epalinges, Switzerland
We tested for antigen recognition and T cell receptor (TCR)–ligand binding 12 peptide derivative variants on seven H-2Kd–restricted cytotoxic T lymphocytes (CTL) clones specific for a bifunctional photoreactive derivative of the Plasmodium berghei circumsporozoite peptide 252– 260 (SYIPSAEKI). The derivative contained iodo-4-azidosalicylic acid in place of PbCS S-252 and 4-azidobenzoic acid on PbCS K-259. Selective photoactivation of the N-terminal photoreactive group allowed crosslinking to Kd molecules and photoactivation of the orthogonal group to TCR. TCR photoaffinity labeling with covalent Kd–peptide derivative complexes allowed direct assessment of TCR–ligand binding on living CTL. In most cases (over 80%) cytotoxicity (chromium release) and TCR–ligand binding differed by less than fivefold. The exceptions included (a) partial TCR agonists (8 cases), for which antigen recognition was fivetenfold less efficient than TCR–ligand binding, (b) TCR antagonists (2 cases), which were not recognized and capable of inhibiting recognition of the wild-type conjugate, (c) heteroclitic agonists (2 cases), for which antigen recognition was more efficient than TCR–ligand binding, and (d) one partial TCR agonist, which activated only Fas (CD95), but not perforin/granzymemediated cytotoxicity. There was no correlation between these divergences and the avidity of TCR–ligand binding, indicating that other factors than binding avidity determine the nature of the CTL response. An unexpected and novel finding was that CD8-dependent clones clearly incline more to TCR antagonism than CD8-independent ones. As there was no correlation between CD8 dependence and the avidity of TCR–ligand binding, the possibility is suggested that CD8 plays a critical role in aberrant CTL function.
Address correspondence to Immanuel F. Luescher, Ludwig Institute for Cancer Research, Chemin des Boveresses 155, CH-1066 Epalinges, Switzerland.
1Abbreviations used in this paper: ABA, 4-azidobenzoic acid; ASA, azidosalicylic; IASA, iodo-4-azidosalicylic acid.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
-
Gil, D., Schrum, A. G., Daniels, M. A., Palmer, E.
(2008). A Role for CD8 in the Developmental Tuning of Antigen Recognition and CD3 Conformational Change. J. Immunol.
180: 3900-3909
[Abstract]
[Full Text]
-
Naeher, D., Daniels, M. A., Hausmann, B., Guillaume, P., Luescher, I., Palmer, E.
(2007). A constant affinity threshold for T cell tolerance. JEM
204: 2553-2559
[Abstract]
[Full Text]
-
Hess, P. R., Barnes, C., Woolard, M. D., Johnson, M. D. L., Cullen, J. M., Collins, E. J., Frelinger, J. A.
(2007). Selective deletion of antigen-specific CD8+ T cells by MHC class I tetramers coupled to the type I ribosome-inactivating protein saporin. Blood
109: 3300-3307
[Abstract]
[Full Text]
-
Guillaume, P., Baumgaertner, P., Angelov, G. S., Speiser, D., Luescher, I. F.
(2006). Fluorescence-Activated Cell Sorting and Cloning of Bona Fide CD8+ CTL with Reversible MHC-Peptide and Antibody Fab' Conjugates. J. Immunol.
177: 3903-3912
[Abstract]
[Full Text]
-
Angelov, G. S., Guillaume, P., Cebecauer, M., Bosshard, G., Dojcinovic, D., Baumgaertner, P., Luescher, I. F.
(2006). Soluble MHC-Peptide Complexes Containing Long Rigid Linkers Abolish CTL-Mediated Cytotoxicity. J. Immunol.
176: 3356-3365
[Abstract]
[Full Text]
-
O'Mahony, D., Kummar, S., Gutierrez, M. E.
(2005). Non-Small-Cell Lung Cancer Vaccine Therapy: A Concise Review. JCO
23: 9022-9028
[Abstract]
[Full Text]
-
Cebecauer, M., Guillaume, P., Mark, S., Michielin, O., Boucheron, N., Bezard, M., Meyer, B. H., Segura, J.-M., Vogel, H., Luescher, I. F.
(2005). CD8+ Cytotoxic T Lymphocyte Activation by Soluble Major Histocompatibility Complex-Peptide Dimers. J. Biol. Chem.
280: 23820-23828
[Abstract]
[Full Text]
-
Cebecauer, M., Guillaume, P., Hozak, P., Mark, S., Everett, H., Schneider, P., Luescher, I. F.
(2005). Soluble MHC-Peptide Complexes Induce Rapid Death of CD8+ CTL. J. Immunol.
174: 6809-6819
[Abstract]
[Full Text]
-
Gonzalez, P. A., Carreno, L. J., Coombs, D., Mora, J. E., Palmieri, E., Goldstein, B., Nathenson, S. G., Kalergis, A. M.
(2005). T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell. Proc. Natl. Acad. Sci. USA
102: 4824-4829
[Abstract]
[Full Text]
-
Favier, B., Burroughs, N. J., Wedderburn, L., Valitutti, S.
(2001). TCR dynamics on the surface of living T cells. Int Immunol
13: 1525-1532
[Abstract]
[Full Text]
-
Rubio-Godoy, V., Dutoit, V., Rimoldi, D., Lienard, D., Lejeune, F., Speiser, D., Guillaume, P., Cerottini, J.-C., Romero, P., Valmori, D.
(2001). Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life. Proc. Natl. Acad. Sci. USA
10.1073/pnas.181348898v1
[Abstract]
[Full Text]
-
Fong, L., Hou, Y., Rivas, A., Benike, C., Yuen, A., Fisher, G. A., Davis, M. M., Engleman, E. G.
(2001). Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy. Proc. Natl. Acad. Sci. USA
10.1073/pnas.141226398v1
[Abstract]
[Full Text]
-
Garcia-Peydro, M., Paradela, A., Albar, J. P., Castro, J. A. L. d.
(2000). Antagonism of Direct Alloreactivity of an HLA-B27-Specific CTL Clone by Altered Peptide Ligands of Its Natural Epitope. J. Immunol.
165: 5680-5685
[Abstract]
[Full Text]
-
Hsieh, M. H., Korngold, R.
(2000). Differential use of FasL- and perforin-mediated cytolytic mechanisms by T-cell subsets involved in graft-versus-myeloid leukemia responses. Blood
96: 1047-1055
[Abstract]
[Full Text]
-
Carrasco-Marin, E., Petzold, S., Unanue, E. R.
(1999). Two Structural States of Complexes of Peptide and Class II Major Histocompatibility Complex Revealed by Photoaffinity-labeled Peptides. J. Biol. Chem.
274: 31333-31340
[Abstract]
[Full Text]
-
Kessler, B., Michielin, O., Blanchard, C. L., Apostolou, I., Delarbre, C., Gachelin, G., Gregoire, C., Malissen, B., Cerottini, J.-C., Wurm, F., Karplus, M., Luescher, I. F.
(1999). T Cell Recognition of Hapten. ANATOMY OF T CELL RECEPTOR BINDING OF A H-2Kd-ASSOCIATED PHOTOREACTIVE PEPTIDE DERIVATIVE. J. Biol. Chem.
274: 3622-3631
[Abstract]
[Full Text]
-
Kessler, B., Hudrisier, D., Schroeter, M., Tschopp, J., Cerottini, J.-C., Luescher, I. F.
(1998). Peptide Modification or Blocking of CD8, Resulting in Weak TCR Signaling, Can Activate CTL for Fas- But Not Perforin-Dependent Cytotoxicity or Cytokine Production. J. Immunol.
161: 6939-6946
[Abstract]
[Full Text]
-
Hudrisier, D., Kessler, B., Valitutti, S., Horvath, C., Cerottini, J.-C., Luescher, I. F.
(1998). The Efficiency of Antigen Recognition by CD8+ CTL Clones Is Determined by the Frequency of Serial TCR Engagement. J. Immunol.
161: 553-562
[Abstract]
[Full Text]
-
Fong, L., Hou, Y., Rivas, A., Benike, C., Yuen, A., Fisher, G. A., Davis, M. M., Engleman, E. G.
(2001). Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy. Proc. Natl. Acad. Sci. USA
98: 8809-8814
[Abstract]
[Full Text]
-
Rubio-Godoy, V., Dutoit, V., Rimoldi, D., Lienard, D., Lejeune, F., Speiser, D., Guillaume, P., Cerottini, J.-C., Romero, P., Valmori, D.
(2001). Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life. Proc. Natl. Acad. Sci. USA
98: 10302-10307
[Abstract]
[Full Text]